Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: The serum cytokine profile and peripheral cell population

Clinical and Experimental Immunology

Volumn 156, Issue 2, 2009, Pages 217-225

  Rong, G ^a   Zhou, Y ^a   Xiong, Y ^a   Zhou, L ^a   Geng, H ^a   Jiang, T ^a   Zhu, Y ^a   Lu, H ^a   Zhang, S ^a   Wang, P ^b   Zhang, B ^c   Zhong, R ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Changzheng Hospital ^*  (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmunity; PBC; Treg cells; Th17 cells

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; PROTEIN P40; RETINOID DERIVATIVE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL CIRCULATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

ADULT; AGED; AUTOIMMUNITY; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 64649097540     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03898.x     Document Type: Article

References (45)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005 353 : 1261 73.
2. Gong Y, Huang Z, Christensen E, Gluud C. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol 2007 102 : 1799 807.
3. Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007 357 : 1524 9.
4. Jones DE. Pathogenesis of primary biliary cirrhosis. Postgrad Med J 2008 84 : 23 33.
5. Selmi C, Mayo MJ, Bach N et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004 127 : 485 92.
6. Xu L, Shen Z, Guo L et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 2003 100 : 8454 9.
7. Amano K, Leung PSC, Rieger R et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005 174 : 5874 83.
8. Foo YL. Th1 and Th2 cells: a historical perspective. Nat Rev Immunol 2002 2 : 55 60.
9. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol 2008 38 : 921 4.
10. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008 28 : 454 67.
11. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001 2 : 816 22.
12. Bettelli E, Oukka M, Kuchroo VK. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007 8 : 345 50.
13. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002 2 : 933 44.
14. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007 8 : 942 9.
15. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 : 179 89.
16. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 8.
17. Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008 38 : 912 15.
18. + T helper cells. Cell 2006 126 : 1121 33.
19. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
20. Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001 292 : 1907 10.
21. Ouyang W, Ranganath SH, Weindel K et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998 9 : 745 55.
22. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007 81 : 1258 68.
23. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000 100 : 655 69.
24. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997 89 : 587 96.
25. Heathcoat EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000 31 : 1005 13.
26. -ΔΔCt method. Methods 2001 25 : 402 8.
27. Su CW, Hung HH, Huo TI et al. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int 2008 28 : 1305 13.
28. Hanck C, Manigold T, Bocker U et al. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis. Gut 2001 49 : 106 11.
29. + lymphocyte subsets in patients with mixed connective tissue disease. Clin Exp Immunol 1992 88 : 91 5.
30. Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 2004 63 : 1300 06.
31. Yamada H, Nakashima Y, Okazaki K et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008 67 : 1299 304.
32. Tzartos JS, Friese MA, Craner MJ et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008 172 : 146 55.
33. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007 204 : 1849 61.
34. Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORgammat function. Nature 2008 453 : 236 40.
35. Manel N, Unutmaz D, Littman DR. The differentiation of human Th17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008 9 : 641 9.
36. Veldhoen M, Uyttenhove C, van SJ et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008 9 : 1341 6.
37. Dardalhon V, Awasthi A, Kwon H et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL9+ IL10+ Foxp3(-) effector T cells. Nat Immunol 2008 9 : 1347 55.
38. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005 201 : 233 40.
39. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003 278 : 1910 4.
40. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 32.
41. Ferrari C, Penna A, Sansoni P, Giuberti T, Fiaccadori F. Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis: isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J Hepatol 1986 3 : 384 92.
42. Niedbala W, Wei X, Cai B et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007 37 : 3021 9.
43. Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007 37 : 2396 9.
44. Mucida D, Park Y, Kim G et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007 317 : 256 60.
45. Kopf H, de la Rosa GM, Howard OMZ, Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol 2007 7 : 1819 24.